Clinical trial
Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
NCT00199862 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00199862 |
|---|---|
| Title | Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer |
| Official title | A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | Ludwig Institute for Cancer Research |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Colorectal Cancer, Colorectal Tumor, COlorectal Carcinoma |
| Intervention type | Drug |
| Interventions | Iodine-124 labeled humanized A33 (antibody) |
| Enrollment | 30 |
| Start date | Feb 1, 2004 |
| Primary completion | Jul 2, 2025 |
| Completion | Jul 2, 2025 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 4, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: